Rinkoo Dalan

Rinkoo Dalan

Auto-generated profile, based on publicly available information

Rinkoo Dalan

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2020 in Nature Reviews Endocrinology
Verified
Journal Article
Open access
PDF file
SBStefan R. Bornstein
Stefan R. Bornstein
RDRinkoo Dalan
Rinkoo Dalan
DHDavid Hopkins
David Hopkins
GMGeltrude Mingrone
Geltrude Mingrone
BBBernhard O. Boehm
Bernhard O. Boehm
Type 2 diabetes mellitus and hypertension are the most common comorbidities in patients with coronavirus infections. Emerging evidence demonstrates an important direct metabolic and endocrine mechanistic link to the viral disease process. Clinicians need to ensure early and thorough metabolic control for all patients affected by COVID-19.

27 April 2020 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
RDRinkoo Dalan
Rinkoo Dalan
SBStefan R. Bornstein
Stefan R. Bornstein
AEAli El-Armouche
Ali El-Armouche
RRRoman N Rodionov
Roman N Rodionov
AMAlexander Markov
Alexander Markov
BBBernhard O. Boehm
Bernhard O. Boehm
COVID-19 is a rapidly spreading outbreak globally. Emerging evidence demonstrates that older individuals and people with underlying metabolic conditions of diabetes mellitus, hypertension, and hyperlipidemia are at higher risk of morbidity and mortality. The SARS-CoV-2 infects humans through the angiotensin converting enzyme (ACE-2) receptor. The ACE-2 receptor is a part of the dual system renin-angiotensin-system (RAS) consisting of ACE-Ang-II-AT1R axis and ACE-2-Ang-(1–7)-Mas axis. In metabolic disorders and with increased age, it is known that there is an upregulation of ACE-Ang-II-AT1R axis with a downregulation of ACE-2-Ang-(1–7)-Mas axis. The activated ACE-Ang-II-AT1R axis leads to pro-inflammatory and pro-fibrotic effects in respiratory system, vascular dysfunction, myocardial fibrosis, nephropathy, and insulin secretory defects with increased insulin resistance. On the other hand, the ACE-2-Ang-(1–7)-Mas axis has anti-inflammatory and antifibrotic effects on the respiratory system and anti-inflammatory, antioxidative stress, and protective effects on vascular function, protects against myocardial fibrosis, nephropathy, pancreatitis, and insulin resistance. In effect, the balance between these two axes may determine the prognosis. The already strained ACE-2-Ang-(1–7)-Mas in metabolic disorders is further stressed due to the use of the ACE-2 by the virus for entry, which affects the prognosis in terms of respiratory compromise. Further evidence needs to be gathered on whether modulation of the renin angiotensin system would be advantageous due to upregulation of Mas activation or harmful due to the concomitant ACE-2 receptor upregulation in the acute management of COVID-19.

27 April 2018 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
EBEveline Bruinstroop
Eveline Bruinstroop
RDRinkoo Dalan
Rinkoo Dalan
YCYang Cao
Yang Cao
YBYong Mong Bee
Yong Mong Bee
KCKurumbian Chandran
Kurumbian Chandran
PYPaul Yen
Paul Yen
Context/Objective Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients with type 2 diabetes mellitus and associated with significant morbidity and mortality. Thyroid hormone (TH) increases β-oxidation of fatty acids and decreases intrahepatic lipid content (IHLC) in rodents with NAFLD. In this study we investigated the possibility of low intrahepatic TH concentration in NAFLD and studied the effect of TH treatment in humans. Design/Setting We performed a phase 2b single arm study in six hospitals in Singapore to study whether TH reduced IHLC. Rats fed a MCD diet to induce NAFLD were used to show intrahepatic thyroid hormone concentrations. Patients Euthyroid patients with type 2 diabetes mellitus and steatosis measured by ultrasonograpy. Intervention Levothyroxine was titrated at TSH 0.34-1.70 mIU/L before a 16-week maintenance phase. Main outcome measures The primary outcome measure was change in IHLC measured by 1H-MRS after treatment. Results 20 male patients were included in the per protocol analysis (mean age 47.8±7.8 years, BMI 30.9±4.4 kg/m2, baseline IHLC 13±4 %). After treatment IHLC was decreased by 12 % ± 26 % relative to baseline (absolute change -2 %; 95% CI -3 to 0, p=0.046). Small decreases in BMI (p=0.044), VAT volume (p=0.047), and SAT volume (p=0.045) were observed. No significant changes in glucose regulation or lipid profile occurred. Conclusions This is the first study demonstrating the efficacy and safety of low dose TH therapy for NAFLD in man, and suggests that TH or TH analogs may be beneficial for this condition.

28 April 2022 in American Journal of Hematology
Verified
Journal Article
Closed access
Bingwen Eugene FanBingwen Eugene Fan
Bingwen Eugene Fan
SWShiun Woei Wong
Shiun Woei Wong
CSChristina Lai Lin Sum
Christina Lai Lin Sum
GLGek Hsiang Lim
Gek Hsiang Lim
BLBernard Leung
Bernard Leung
TIThe COVID‐19 Clotting and Bleeding Investigators
The COVID‐19 Clotting and Bleeding Investigators

15 October 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WTWilnard Y. T. Tan
Wilnard Y. T. Tan
BYBarnaby E. Young
Barnaby E. Young
DLDavid Chien Lye
David Chien Lye
DCDaniel E. K. Chew
Daniel E. K. Chew
RDRinkoo Dalan
Rinkoo Dalan
We aim to study the association of hyperlipidemia and statin use with COVID-19 severity. We analysed a retrospective cohort of 717 patients admitted to a tertiary centre in Singapore for COVID-19 infection. Clinical outcomes of interest were oxygen saturation ≤ 94% requiring supplemental oxygen, intensive-care unit (ICU) admission, invasive mechanical-ventilation and death. Patients on long term dyslipidaemia medications (statins, fibrates or ezetimibe) were considered to have dyslipidaemia. Logistic regression models were used to study the association between dyslipidaemia and clinical outcomes adjusted for age, gender and ethnicity. Statin treatment effect was determined, in a nested case–control design, through logistic treatment models with 1:3 propensity matching for age, gender and ethnicity. All statistical tests were two-sided, and statistical significance was taken as p < 0.05. One hundred fifty-six (21.8%) patients had dyslipidaemia and 97% of these were on statins. Logistic treatment models showed a lower chance of ICU admission for statin users when compared to non-statin users (ATET: Coeff (risk difference): − 0.12 (− 0.23, − 0.01); p = 0.028). There were no other significant differences in other outcomes. Statin use was independently associated with lower ICU admission. This supports current practice to continue prescription of statins in COVID-19 patients.

2 January 2018 in APL Bioengineering
Verified
Journal Article
Open access
PDF file
NMNishanth Venugopal Menon
Nishanth Venugopal Menon
HTHui Min Tay
Hui Min Tay
KPKuin Tian Pang
Kuin Tian Pang
RDRinkoo Dalan
Rinkoo Dalan
SWSiew Cheng Wong
Siew Cheng Wong
HHHan Wei Hou
Han Wei Hou
Atherosclerosis, a chronic inflammatory disorder characterized by endothelial dysfunction and blood vessel narrowing, is the leading cause of cardiovascular diseases including heart attack and stroke. Herein, we present a novel tunable microfluidic atherosclerosis model to study vascular inflammation and leukocyte-endothelial interactions in 3D vessel stenosis. Flow and shear stress profiles were characterized in pneumatic-controlled stenosis conditions (0%, 50% and 80% constriction) using fluid simulation and experimental beads perfusion. Due to non-uniform fluid flow at the 3D stenosis, distinct monocyte (THP-1) adhesion patterns on inflamed [tumor necrosis factor-α (TNF-α) treated] endothelium were observed, and there was a differential endothelial expression of intercellular adhesion molecule-1 (ICAM-1) at the constriction region. Whole blood perfusion studies also showed increased leukocyte interactions (cell rolling and adherence) at the stenosis of healthy and inflamed endothelium, clearly highlighting the importance of vascular inflammation, flow disturbance, and vessel geometry in recapitulating atherogenic microenvironment. To demonstrate inflammatory risk assessment using leukocytes as functional biomarkers, we perfused whole blood samples into the developed microdevices (80% constriction) and observed significant dose-dependent effects of leukocyte adhesion in healthy and inflamed (TNF-α treated) blood samples. Taken together, the 3D stenosis chip facilitates quantitative study of hemodynamics and leukocyte-endothelial interactions, and can be further developed into a point-of-care blood profiling device for atherosclerosis and other vascular diseases.